Cargando…

Treatment with Raltegravir, a retroviral integrase inhibitor, in patients infected with HTLV-1

Detalles Bibliográficos
Autores principales:	Treviño, Ana, de Mendoza, Carmen, Parra, Patricia, Eiros, Jose M, de Lejarazu, Raul Ortiz, Soriano, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112769/ http://dx.doi.org/10.1186/1742-4690-8-S1-A55

Ejemplares similares

Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain
por: Treviño, Ana, et al.
Publicado: (2011)

Seroprevalence of HTLV infection in Spain among immigrant pregnant women
por: Treviño, Ana, et al.
Publicado: (2011)

Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain
por: Treviño, Ana, et al.
Publicado: (2012)

Raltegravir: first in class HIV integrase inhibitor
por: Temesgen, Zelalem, et al.
Publicado: (2008)

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2021)

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
por: Serrao, Erik, et al.
Publicado: (2009)

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
por: Serrao, Erik, et al.
Publicado: (2009)

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
por: Doyle, Tomas, et al.
Publicado: (2015)

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
por: Bercoff, Danielle Perez, et al.
Publicado: (2010)

Unprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir
por: Ammar, Farah F., et al.
Publicado: (2012)

Integrase inhibitors effective against human T-cell leukemia virus type 1
por: Seegulam, Muhammad E, et al.
Publicado: (2011)

Expression of the HBZ and tax genes of HTLV-1in infective dermatitis associated with HTLV-I (IDH)
por: Batista, Everton S, et al.
Publicado: (2011)

The utilization of humanized mouse models for the study of inhibitors in HTLV-1 infection
por: Van Duyne, Rachel, et al.
Publicado: (2011)

Raltegravir-Induced Adaptations of the HIV-1 Integrase: Analysis of Structure, Variability, and Mutation Co-occurrence
por: Machado, Lucas de Almeida, et al.
Publicado: (2019)

Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
por: Araujo, Thessika H A, et al.
Publicado: (2011)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
por: Ferrer, Pablo, et al.
Publicado: (2020)

New insights into HTLV entry
por: Pique, Claudine, et al.
Publicado: (2011)

Analysis of temporal expression of HTLV-2 reveals similarities and functional differences from HTLV-1
por: Bender, Cecilia, et al.
Publicado: (2011)

The reverse genetics of HTLV-1 infected patients
por: Alcantara, Luiz C, et al.
Publicado: (2011)

Arsenic trioxyde in the treatment of HTLV1 associated ATLL
por: Suarez, Felipe, et al.
Publicado: (2011)

Quality of life (QOL) and depression in HTLV-1 carriers
por: Galvão-Phileto, Ana V, et al.
Publicado: (2011)

Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
por: Abdelbary, Nashwa H, et al.
Publicado: (2011)

Biochemical Characterization of Novel Retroviral Integrase Proteins
por: Ballandras-Colas, Allison, et al.
Publicado: (2013)

Prevalence of HTLV-1/2 and HIV-1/2 in individuals attending Public Health Center in Mozambique. One HTLV-1 symptomatic case report
por: Caterino-de-Araujo, Adele, et al.
Publicado: (2011)

Comparative structural analysis of retroviral fusion proteins identifies regions that modulate membrane fusion: a potential retroviral achilles heal?
por: Lamb, Daniel, et al.
Publicado: (2011)

HTLV-1 infection and associated diseases in Peruvian twins probably exposed to HTLV-1 mother-to-child transmission
por: Alvarez, Carolina, et al.
Publicado: (2011)

Cellular tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)
por: Kannian, Priya, et al.
Publicado: (2011)

MicroRNA expression in HTLV-1 infection and pathogenesis
por: D'Agostino, Donna M, et al.
Publicado: (2011)

Transformation of human embryonic stem cells by HTLV-1 Tax
por: Zane, Linda, et al.
Publicado: (2011)

Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1)-positive and HTLV-1-negative polymyositis
por: Abdullah, Hazem M, et al.
Publicado: (2011)

HTLV-3 and HTLV-4 antisense proteins activate JunB-, c-Jun- and JunD-dependent transcription
por: Larocque, Émilie, et al.
Publicado: (2011)

Influence of HTLV-1 in the clinic, microbiologic and immunologic features of tuberculosis
por: de Lourdes S Bastos, Maria, et al.
Publicado: (2011)

Structural Basis of Mos1 Transposase Inhibition by the Anti-retroviral Drug Raltegravir
por: Wolkowicz, Urszula M., et al.
Publicado: (2014)

Prototype Foamy Virus Integrase Displays Unique Biochemical Activities among Retroviral Integrases
por: Rabe, Anthony J., et al.
Publicado: (2021)

Mother-to-child transmission of HTLV-1:in vitro study of HTLV-1 passage across a tight human epithelial barrier
por: Martin-Latil, Sandra, et al.
Publicado: (2011)

Immunological characteristics of Spanish IDUs infected with HTLV-2 and HIV-1
por: Abad, Maria, et al.
Publicado: (2011)

Persistent high HTLV-1 proviral load in a patient with complete remission of Adult T-cell leukemia/lymphoma (ATL)
por: Mangano, Andrea, et al.
Publicado: (2011)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

The N-end rule and retroviral infection: no effect on integrase
por: Boso, Guney, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jrskucnmjkqn154jlgq4oe3tof